The IPO will include fresh issue of equity shares aggregating upto Rs 250 crore and/or an offer of sale of equity shares by certain existing and eligible shareholders of the company. As at 31st March 2021, Balaji Amines owned 55% stake in BSCL. It was incorporated in the year 2010, and it makes unique products like Ethylenediamine (EDA), Piperazine (Anhydrous), Diethylene Triamine (DETA) & Aminoethyliperazine (AEP). During 2021, Balaji Speciality Chemical recorded a total income of Rs 1,81,32,18,571 and net profit of Rs 11,78,45,833. Balaji Amines is a leading manufacturer of aliphatic amines & speciality chemicals in India, specialized in manufacturing of methyl amines, ethyl amines, derivatives of amines and other specialty chemicals. It reported 29% rise in consolidated net profit to Rs 108.72 crore on a 88% increase in revenue from operations to Rs 779.04 crore in Q4 FY22 over Q4 FY21. Balaji Amines, as a shareholder, will consider and finalise its participation in the offer of BSCL, it said. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.